EndoClot Plus Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

EndoClot Plus General Information

Description

Manufacturer of medical devices designed for gastrointestinal bleeding control. The company's technology utilizes absorbable modified polymer particles and controlled air pressure delivery to accelerate natural clotting, providing healthcare providers with polysaccharide hemostatic systems, adhesive hemostatic polymers, submucosal injection systems, portable air compressors, and hemostatic powder applicators to stop bleeding rapidly during endoscopic procedures.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101st Floor, Building B8, BioNano Park
  • Number 218 Xinghu Street Suzhou Industrial Park Suzhou Area of China Pilot Free Trade Zone
  • Suzhou, Jiangsu 215123
  • China
+86 0512
Primary Industry
Medical Supplies
Corporate Office
  • 101st Floor, Building B8, BioNano Park
  • Number 218 Xinghu Street Suzhou Industrial Park Suzhou Area of China Pilot Free Trade Zone
  • Suzhou, Jiangsu 215123
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EndoClot Plus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 29-Oct-2025 Completed Generating Revenue
4. Secondary Transaction - Private 27-Jan-2025 Completed Generating Revenue
3. Secondary Transaction - Private 24-Dec-2020 Completed Generating Revenue
2. Early Stage VC (Series B) 26-Oct-2018 Completed Generating Revenue
1. Early Stage VC (Series A) 25-Aug-2016 Completed Startup
To view EndoClot Plus’s complete valuation and funding history, request access »

EndoClot Plus Patents

EndoClot Plus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20110178495-A1 Internal dry powder delivery system and method thereof Active 15-Jan-2010
US-20130046278-A1 Internal dry powder delivery system and method thereof Active 15-Jan-2010
US-20140207097-A1 Internal dry powder delivery system and method thereof Active 15-Jan-2010
US-8827980-B2 Internal dry powder delivery system and method thereof Active 15-Jan-2010
US-9205207-B2 Internal dry powder delivery system and method thereof Active 15-Jan-2010 A61M13/00
To view EndoClot Plus’s complete patent history, request access »

EndoClot Plus Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
LYFE Capital PE/Buyout Minority
To view EndoClot Plus’s complete investors history, request access »

EndoClot Plus FAQs

  • When was EndoClot Plus founded?

    EndoClot Plus was founded in 2014.

  • Where is EndoClot Plus headquartered?

    EndoClot Plus is headquartered in Suzhou, China.

  • What industry is EndoClot Plus in?

    EndoClot Plus’s primary industry is Medical Supplies.

  • Is EndoClot Plus a private or public company?

    EndoClot Plus is a Private company.

  • What is EndoClot Plus’s current revenue?

    The current revenue for EndoClot Plus is .

  • Who are EndoClot Plus’s investors?

    LYFE Capital has invested in EndoClot Plus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process